Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors

NCT00003292 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00003292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S9624: Phase II Study of Ifosfamide in Patients With Aggressive Meningeal Tumors
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 1998
Completion date
January 31, 2004
Enrollment
7 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

adult brain malignant hemangiopericytoma, adult fibrosarcoma, adult leiomyosarcoma, adult malignant meningioma, adult rhabdomyosarcoma, chondrosarcoma